Forrester Research Faces AI Headwinds: A 'Sell' Rating Justified by Declining Performance and Market Shifts
Finance

Forrester Research Faces AI Headwinds: A 'Sell' Rating Justified by Declining Performance and Market Shifts

authorBy Fareed Zakaria
DateJun 30, 2026
Read time3 min

Forrester Research (FORR) finds itself in a precarious position, warranting a 'SELL' rating due to a confluence of factors that signal persistent challenges and an uncertain future. The company has experienced a steady erosion in key performance indicators, including contract value and client acquisition, further compounded by diminishing clarity in its earnings outlook. This downturn is significantly amplified by the burgeoning influence of artificial intelligence (AI), which is empowering clients to conduct their own in-depth research, thereby reducing their reliance on traditional research providers like Forrester. While the company's leadership is actively exploring and developing AI-integrated offerings, the current rate of client adoption and the ability to monetize these new products remain largely unproven. Despite maintaining a robust balance sheet, Forrester's present valuation appears unattractive given these formidable structural headwinds, coupled with negative operating leverage and constrained free cash flow.

Forrester Research (FORR) has witnessed a substantial decline in its stock value over the past five years, reflecting deep-seated market apprehension. The primary concern revolves around the transformative impact of artificial intelligence. As AI technologies become more sophisticated and accessible, a growing number of businesses are leveraging these tools to generate proprietary research insights. This shift diminishes their dependency on external market and strategy content subscriptions, which historically formed the core of Forrester's revenue model. Consequently, Forrester has observed a continuous decrease in its contractual agreements and client base, indicating a fundamental challenge to its business model in the evolving technological landscape.

In response to these market dynamics, Forrester's management has initiated efforts to integrate AI into its product portfolio. However, these initiatives are still in their nascent stages, facing hurdles in gaining widespread client acceptance and demonstrating a clear path to monetization. The slow uptake of AI-enhanced products raises questions about the company's ability to effectively pivot and adapt to the rapid advancements in AI and its pervasive influence on market research practices. The investment community is keenly observing whether these AI ventures can effectively counteract the ongoing erosion of Forrester's traditional revenue streams and re-establish its competitive edge.

Despite these operational and market challenges, Forrester maintains a strong balance sheet, which offers some degree of financial stability. Nevertheless, this strength is insufficient to offset concerns regarding its valuation. The combination of structural changes in the market, negative operating leverage (where revenue growth does not proportionately translate into profit growth), and weak free cash flow renders the company's stock unappealing to investors. These elements collectively suggest that, without significant and successful strategic shifts, Forrester Research may continue to struggle in regaining its market position and investor confidence.

Forrester Research is currently navigating a period of significant disruption, primarily driven by the rapid evolution of artificial intelligence. The shift in client behavior towards in-house AI-powered research is directly impacting the company's core business, leading to declining client numbers and contract values. Although management is endeavoring to innovate with AI-enhanced solutions, the practical adoption and financial returns from these new offerings are yet to materialize. This scenario, combined with a valuation that does not adequately reflect these operational difficulties, points to a challenging outlook for the company, despite its underlying financial strength.

More Articles
Finance
Vertex Pharmaceuticals: Pioneering Biotech Dominance and Diversification
Vertex Pharmaceuticals maintains a strong position in the cystic fibrosis market, ensuring stable revenue. The company is strategically expanding into new therapeutic areas like pain, hematology, and renal diseases, with promising drug candidates such as Pove for IgAN. Early successes in non-CF treatments like Journavx and Casgevy are boosting growth, and Pove is anticipated to be a major revenue contributor post-2027. Vertex's robust pipeline, strong financial health, and strategic vision position it for sustained market-beating returns.
By Morgan HouselJun 30, 2026
Finance
Kohl's Performance Review: A Bearish Outlook Continues Despite Modest Sales Improvement
Kohl's recently reported its quarterly earnings, showing a sales decline of only 1.7%, the smallest in four years. Despite this modest improvement and the traction gained by proprietary brands and new Sephora products, some segments, like makeup, underperformed. The valuation may appear attractive, but the underlying fundamentals do not support an appealing investment for value or dividend-focused investors. The author maintains a sell rating, though speculative investors might find opportunity in the high short interest.
By Morgan HouselJun 30, 2026
Finance
Understanding the Sophisticated Investor: Benefits, Regulations, and Tax Strategies
Sophisticated investors are defined by their substantial capital, extensive experience, and high net worth, granting them access to unique investment opportunities not available to the general public. These opportunities include private placements, venture capital, and hedge funds, often coming with favorable terms and pricing. While these investors enjoy potential for higher returns and enhanced portfolio diversification, they must also navigate complex tax implications and inherent risks, despite their expertise.
By Morgan HouselJun 30, 2026
Finance
Navigating BDC Valuations: Opportunities Amidst Pessimism
The Business Development Company (BDC) sector currently presents a complex landscape for investors. While valuations have plummeted to near pandemic levels, creating potential 'buy-the-dip' scenarios, not all BDCs are created equal. This analysis delves into the market's current skepticism towards BDCs and highlights why some seemingly attractive options, specifically MAIN and TSLX, may not be the best long-term investments, despite their reduced prices.
By Nouriel RoubiniJun 30, 2026
Finance
SM Energy: Strong Buy Rating Amidst Growth and Market Dynamics
SM Energy (SM) is currently rated as a 'Strong Buy,' trading at a 70% discount compared to its sector peers. The company has demonstrated significant growth in its asset base and operational efficiency through recent mergers and acquisitions, expanding to 800,000 net acres and increasing oil and natural gas liquids (NGL) output. Despite temporary derivative losses from Civitas, which are expected to reverse by 2027, SM is poised for substantial revenue growth, particularly from its gas and NGL segments as the Permian Basin shifts towards higher gas production.
By Michele FerreroJun 30, 2026